Pacira Biosciences Inc (PCRX)

Operating Expenses

$572.57M

TTM · Period ending: · USD

PCRX logo

PCRX Operating Expenses

Latest reported$572.57M
PCRX TTM Operating Expenses ($24.66M → $572.57M)
High-resolution chart · PNG

PCRX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pacira Biosciences Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
572,565,000
560,331,000
556,620,000
525,900,000
656,260,000
630,047,000
603,909,000
581,630,000
418,849,000
394,711,000
402,634,000
422,182,000
411,226,000
417,392,000
407,504,000
403,548,000
369,687,000
347,637,000
311,354,000
272,273,000
280,506,000
275,354,000
265,971,000
277,883,000
280,362,000
288,738,000
292,782,000
262,796,000
249,522,000
237,287,000
232,954,000
223,339,000
216,682,000
218,602,000
218,785,000
221,321,000
214,970,000
209,593,000
198,291,000
197,255,000
192,390,000
177,760,000
167,705,000
151,904,000
143,343,000
134,995,000
125,393,000
115,496,000
104,136,000
93,020,000
84,068,000
75,667,000
69,290,000
62,638,000
56,243,000
48,966,000
43,393,000
40,160,000
35,032,000
31,465,000
29,543,000
26,325,000
24,660,000
27,513,000
27,264,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.